Ronil A. Patel - 01 Dec 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (IRD)

Role: Chief Business Officer
Signature: /s/ Stephanie Swan, by Power of Attorney
Issuer symbol: IRD
Transactions as of: 01 Dec 2023
Net transactions value: $0
Form type: 4
Filing time: 05 Dec 2023, 16:30:39 UTC
Previous filing: 26 Apr 2023
Next filing: 12 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUP	Common Stock	Award	$0	+49,692	+117%	$0.000000	91,996	01 Dec 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUP	Employee Stock Option (right to buy)	Award	$0	+74,538		$0.000000	74,538	01 Dec 2023	Common Stock	74,538	$2.99	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest with respect to 25% on the six month anniversary of the grant date, with the remaining shares vesting in equal installments every six months thereafter over the two years following the grant date, subject to continuing service.
F2	The option will vest with respect to 25% on the six month anniversary of the grant date, with the remaining shares vesting in equal installments every six months thereafter over the two years following the grant date, subject to continuing service.